Home
NewsNewsThe AI-specialized Infertility Center, which is the largest in Asia, is open in Magok, Seoul and has begun its full-scale medical services from November 17 thereby marking the new era when it comes to fertility in the region.
CHA Hospital, which is a medical institution that specializes in infertility treatment, has gone on to open the first artificial intelligence: AI-specialized infertility center in the Magok district of Seoul.
On November 12, CHA Hospital announced that Magok CHA Hospital, which happens to feature the largest scale of 6,611 square meters along with 5 operating rooms, 9 consultation rooms, an AI egg bank, and clean room culture facilities that meet the international benchmarks, will start its full-scale medical services on November 17, 2025.
It is well to be noted that CHA Hospital, with its AI-specialized Infertility Center, looks to execute a future-oriented infertility treatment model, which happens to be based on precision medicine through combining the massive reproductive medicine data that’s accumulated by CHA Hospital Group in the last 65 years due to AI technology and, of course, the patient-centered treatment philosophy. CHA Hospital's general director and leading authority on domestic infertility treatment, Han Se-yeol, is joined by the former Seoul National University professor who delivered Korea's first test-tube baby, Moon Shin-yong.
Moon Shin-yong has joined as the honorary director. The well-versed medical staff includes the likes of Yeom Seon-hyeong and Profs. Yang Nu-ri and Lim Jeong-mi, as well as Kim Ji-eun from the Seoul Station Center, and also Prof. Jeong Ja-yeon, who happens to be from Bundang CHA Hospital all of whom have joined to plan tailor-made treatment for patients who are experiencing difficulties when it comes to pregnancy. Being an industry first, the hospital has gone in to recruit AI specialists and is also going to showcase precision infertility treatment by way of advanced systems, including AI embryo grading classification, reproductive cell - sperm/egg AI automatic analysis, implantation possibility prediction, and also PGT -preimplantation genetic testing auxiliary analysis.
AI technology is also going to be applied to the egg freezing field so as to accurately predict egg quality and also freezing timing as well as anticipate and analyze the embryo formation probabilities post thawing to support the fertility preservation of women. Infertility researchers having over 20 years of experience are going to work along with medical staff in order to make sure of high rates of pregnancy success. Apparently, the first infertility center-specialized KareChat service in Korea is also going to be introduced. KareChat is indeed a smart healthcare platform that enables convenient usage of hospital appointment booking and infertility-related educational content based on KakaoTalk and also schedule changes without even installing any separate application. By doing this, infertility patients can seamlessly go ahead and check essential information before visiting the hospital and, at the same time, conveniently manage schedules pertaining to personalized infertility treatment.
Given the excellent airport accessibility of the hospital, it looks forward to making Magok the hub when it comes to K-infertility through connecting with the hotels nearby.
The director of Magok CHA Hospital, Han Se-yeol, remarked that in an era where scientific as well as technological advancement along with artificial intelligence go on to lead the medical changes, they are going to offer more scientific and accurate customized treatment services by way of combining cutting-edge technology. He further added that if Jamsil CHA Hospital goes on to open the first in vitro maturation IVM specialized research center in Korea in 2024 so as to present the probability of customized test-tube procedures, Magok CHA Hospital is going to write a completely new paradigm when it comes to complete infertility treatment that is based on AI.
Fertility care leader IVI RMA North America announces a new partnership with Island Reproductive Services
Overture Life’s DaVitri fertility automation platform gains CE Mark, paving the way for wider IVF and egg freezing access in Europe.
Simbryo Technologies introduces the Simbryo FX personalized assay, a diagnostic test that measures endometrial fertility to predict embryo implantation success and improve IVF outcomes with more than 90% specificity.
Technology-Enabled Cryostorage is transforming fertility storage as Reprotech and TMRW combine expertise in digital specimen management and biorepository services. The partnership enhances scalability, safety, and efficiency while supporting clinics with advanced solutions. This strategic move positions the combined company to lead innovation and meet growing global demand in cryostorage services.
CDSCO Orders on IVF Medical Devices reinforce strict regulatory oversight across India’s fertility sector. The directive mandates licensing compliance under existing laws, ensuring IVF and ART devices meet safety and quality standards. This move aims to curb unauthorized sales, strengthen enforcement, and bring greater accountability to medical device usage in reproductive healthcare.
The Tennessee State Law could change how the embryos are handled at the time of treatment, thereby making the IVF clinic services in the state more expensive for patients seeking fertility care.
Before taking a call on IVF, survey conducted in the U.S., UK, Ireland, and Canada suggests that people are looking for complete & less expensive options to treat root causes of infertility.
